One of the most common underlying pathological processes is related to the alteration of gene and protein expression that leads to the impairment of insulin sensitivity and glucose homeostasis, and a vast number of reports has shown altered patterns of miRNAs and RBPs expression during metabolic diseases. The gene discussed is INS; the disease is metabolic disease.